BASILE EDWARD M sold 63.6% of their position (5K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $632.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/29/2025ACC: 0000950170-25-079022
-5K
Net shares
Net seller
$632.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$0.70
Trade value
$3.50K
% of position
174.5%
5/27/2025
2.87K→7.87K
Common Stock
Direct
Shares
−5K
Price / share
$126.45
Trade value
$632.25K
% of position
63.6%
5/27/2025
7.87K→2.87K
Total
Net shares
+0.00
Net value
-$628.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2025 | M · Option Exercise | +5K | $0.70 | $3.50K | 174.5% | 2.87K | 7.87K |
| Common Stock Direct | 5/27/2025 | S · Sale | −5K | $126.45 | $632.25K | 63.6% | 7.87K | 2.87K |
| Total | +0.00 | -$628.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
0.7
Held after
8.29K
Exercisable
—
5/27/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 5/27/2025 | M · Option Exercise | −5K | 0.7 | — | 8.29K |